International Market Entry Costs for US Biotech
International market entry represents a critical inflection point for US biotech companies seeking to expand beyond domestic commercialization. While global markets offer access to larger patient populations and diversified revenue streams, the cost structure associated with entry is complex, highly regulated, and varies significantly across regions. Strategic planning must account for regulatory pathways, infrastructure investments, … Read more